SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-043591
Filing Date
2024-05-15
Accepted
2024-05-15 16:06:00
Documents
70
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0205867-10q_chinapharma.htm   iXBRL 10-Q 489303
2 CERTIFICATION ea020586701ex31-1_china.htm EX-31.1 10531
3 CERTIFICATION ea020586701ex31-2_china.htm EX-31.2 10279
4 CERTIFICATION ea020586701ex32-1_china.htm EX-32.1 6677
  Complete submission text file 0001213900-24-043591.txt   4033295

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cphi-20240331.xsd EX-101.SCH 43557
6 XBRL CALCULATION FILE cphi-20240331_cal.xml EX-101.CAL 41596
7 XBRL DEFINITION FILE cphi-20240331_def.xml EX-101.DEF 233515
8 XBRL LABEL FILE cphi-20240331_lab.xml EX-101.LAB 399864
9 XBRL PRESENTATION FILE cphi-20240331_pre.xml EX-101.PRE 239547
74 EXTRACTED XBRL INSTANCE DOCUMENT ea0205867-10q_chinapharma_htm.xml XML 335240
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 24950434
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)